Showing results (21-30 of 62) with videos related to
Sort By:
Pageof 7
Frontiers in Immunology|August 9, 2021
CAR Macrophages for SARS-CoV-2 ImmunotherapyWenyan Fu, Changhai Lei, Zetong Ma, et al.Theranostics|October 8, 2019
BCAP31 drives TNBC development by modulating ligand-independent EGFR trafficking and spontaneous EGFR phosphorylationWenyan Fu, Hefen Sun, Yang Zhao, et al.Frontiers in Immunology|February 6, 2023
Engineered soluble ACE2 receptor: Responding to change with changeGuangyao Li, Kewen Qian, Shuyi Zhang, et al.The International Journal of Cardiovascular Imaging|May 30, 2023
Evaluation of left ventricular function of pregnant women with autoimmune diseases using speckle tracking echocardiographyLu Zhang, YaXi Wang, WuPing Xiao, et al.Theranostics|July 13, 2023
Bispecific antibodies targeting EGFR/Notch enhance the response to talazoparib by decreasing tumour-initiating cell frequencyWenyan Fu, Guangyao Li, Changhai Lei, et al.Nature Communications|April 26, 2020
Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-IgChanghai Lei, Kewen Qian, Tian Li, et al.Frontiers in Immunology|April 12, 2021
TIGIT-Fc as a Potential Therapeutic Agent for Fetomaternal ToleranceWenyan Fu, Renfei Cai, Zetong Ma, et al.Water Science and Technology : a Journal of the International Association on Water Pollution Research|April 13, 2013
Extraction of trace tilmicosin in real water samples using ionic liquid-based aqueous two-phase systemsRu Pan, Dejia Shao, Xueyong Qi, et al.Molecular Immunology|May 20, 2018
Targeted delivery of CD44s-siRNA by ScFv overcomes de novo resistance to cetuximab in triple negative breast cancerWenyan Fu, Hefen Sun, Yang Zhao, et al.View (Beijing, China)|November 12, 2021
Therapeutic antibodies under development for SARS-CoV-2Zetong Ma, MengMei Zhu, Shuyi Zhang, et al.Pageof 7